These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Assessment of Prolonged Dengue Virus Infection in Dermal Fibroblasts and Hair-Follicle Dermal Papilla Cells. Wei KC; Wei WJ; Liu YS; Yen LC; Chang TH Viruses; 2020 Feb; 12(3):. PubMed ID: 32121148 [TBL] [Abstract][Full Text] [Related]
3. Dengue virus (DENV) antibody-dependent enhancement of infection upregulates the production of anti-inflammatory cytokines, but suppresses anti-DENV free radical and pro-inflammatory cytokine production, in THP-1 cells. Chareonsirisuthigul T; Kalayanarooj S; Ubol S J Gen Virol; 2007 Feb; 88(Pt 2):365-375. PubMed ID: 17251552 [TBL] [Abstract][Full Text] [Related]
4. Susceptibility and initial immune response of Tupaia belangeri cells to dengue virus infection. Kayesh MEH; Kitab B; Sanada T; Hayasaka D; Morita K; Kohara M; Tsukiyama-Kohara K Infect Genet Evol; 2017 Jul; 51():203-210. PubMed ID: 28392469 [TBL] [Abstract][Full Text] [Related]
5. The expression profile of human peripheral blood mononuclear cell miRNA is altered by antibody-dependent enhancement of infection with dengue virus serotype 3. Jiang L; Sun Q Virol J; 2018 Mar; 15(1):50. PubMed ID: 29566761 [TBL] [Abstract][Full Text] [Related]
6. The cytokine response of U937-derived macrophages infected through antibody-dependent enhancement of dengue virus disrupts cell apical-junction complexes and increases vascular permeability. Puerta-Guardo H; Raya-Sandino A; González-Mariscal L; Rosales VH; Ayala-Dávila J; Chávez-Mungía B; Martínez-Fong D; Medina F; Ludert JE; del Angel RM J Virol; 2013 Jul; 87(13):7486-501. PubMed ID: 23616663 [TBL] [Abstract][Full Text] [Related]
7. Tumour necrosis factor alpha (TNF-alpha) stimulation of cells with established dengue virus type 2 infection induces cell death that is accompanied by a reduced ability of TNF-alpha to activate nuclear factor kappaB and reduced sphingosine kinase-1 activity. Wati S; Rawlinson SM; Ivanov RA; Dorstyn L; Beard MR; Jans DA; Pitson SM; Burrell CJ; Li P; Carr JM J Gen Virol; 2011 Apr; 92(Pt 4):807-18. PubMed ID: 21148274 [TBL] [Abstract][Full Text] [Related]
8. Substitution of the precursor peptide prevents anti-prM antibody-mediated antibody-dependent enhancement of dengue virus infection. Wang Y; Si LL; Guo XL; Cui GH; Fang DY; Zhou JM; Yan HJ; Jiang LF Virus Res; 2017 Feb; 229():57-64. PubMed ID: 27939945 [TBL] [Abstract][Full Text] [Related]
9. Dengue virus infection induces interferon-lambda1 to facilitate cell migration. Hsu YL; Wang MY; Ho LJ; Lai JH Sci Rep; 2016 Jul; 6():24530. PubMed ID: 27456172 [TBL] [Abstract][Full Text] [Related]
10. Modulation of Dengue/Zika Virus Pathogenicity by Antibody-Dependent Enhancement and Strategies to Protect Against Enhancement in Zika Virus Infection. Khandia R; Munjal A; Dhama K; Karthik K; Tiwari R; Malik YS; Singh RK; Chaicumpa W Front Immunol; 2018; 9():597. PubMed ID: 29740424 [TBL] [Abstract][Full Text] [Related]
11. Antibody-dependent enhancement of dengue virus infection inhibits RLR-mediated Type-I IFN-independent signalling through upregulation of cellular autophagy. Huang X; Yue Y; Li D; Zhao Y; Qiu L; Chen J; Pan Y; Xi J; Wang X; Sun Q; Li Q Sci Rep; 2016 Feb; 6():22303. PubMed ID: 26923481 [TBL] [Abstract][Full Text] [Related]
12. Dengue virus infects the mouse eye following systemic or intracranial infection and induces inflammatory responses. Norbury AJ; Calvert JK; Al-Shujairi WH; Cabezas-Falcon S; Tang V; Ong LC; Alonso SL; Smith JR; Carr JM J Gen Virol; 2020 Jan; 101(1):79-85. PubMed ID: 31774391 [TBL] [Abstract][Full Text] [Related]
13. Mechanisms of monocyte cell death triggered by dengue virus infection. Castillo JA; Urcuqui-Inchima S Apoptosis; 2018 Dec; 23(11-12):576-586. PubMed ID: 30267240 [TBL] [Abstract][Full Text] [Related]
14. Lower activation-induced T-cell apoptosis is related to the pathological immune response in secondary infection with hetero-serotype dengue virus. Yang W; Yan H; Ma Y; Yu T; Guo H; Kuang Y; Ren R; Li J Immunobiology; 2016 Mar; 221(3):432-9. PubMed ID: 26655144 [TBL] [Abstract][Full Text] [Related]
15. Dengue Virus Infection with Highly Neutralizing Levels of Cross-Reactive Antibodies Causes Acute Lethal Small Intestinal Pathology without a High Level of Viremia in Mice. Watanabe S; Chan KW; Wang J; Rivino L; Lok SM; Vasudevan SG J Virol; 2015 Jun; 89(11):5847-61. PubMed ID: 25787279 [TBL] [Abstract][Full Text] [Related]
17. Hyun J; Im J; Kim SW; Kim HY; Seo I; Bhang SH Pharmaceutics; 2021 Jul; 13(8):. PubMed ID: 34452116 [TBL] [Abstract][Full Text] [Related]
18. Antibody with an engineered Fc region as a therapeutic agent against dengue virus infection. Ramadhany R; Hirai I; Sasaki T; Ono K; Ramasoota P; Ikuta K; Kurosu T Antiviral Res; 2015 Dec; 124():61-8. PubMed ID: 26522769 [TBL] [Abstract][Full Text] [Related]
19. Antibody-dependent enhancement of dengue virus infection in vitro by undiluted sera from monkeys infected with heterotypic dengue virus. Ito M; Mukai RZ; Takasaki T; Kotaki A; Kurane I Arch Virol; 2010 Oct; 155(10):1617-24. PubMed ID: 20644969 [TBL] [Abstract][Full Text] [Related]
20. Hair Growth Promoting Effects of 15-Hydroxyprostaglandin Dehydrogenase Inhibitor in Human Follicle Dermal Papilla Cells. Lim HW; Kim HJ; Jeon CY; Lee Y; Kim M; Kim J; Kim SR; Lee S; Lim DC; Park HD; Park BC; Shin DW Int J Mol Sci; 2024 Jul; 25(13):. PubMed ID: 39000592 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]